Published in Soins on November 21, 1979
Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys (2000) 2.58
Application of the LQ model to the interpretation of absorbed dose distribution in the daily practice of radiotherapy. Radiother Oncol (1991) 2.01
Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood (1991) 1.88
The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis. Br J Cancer (1998) 1.75
ICRP publication 112. A report of preventing accidental exposures from new external beam radiation therapy technologies. Ann ICRP (2009) 1.73
Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys (1993) 1.60
Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys (1995) 1.52
Radiotherapy after ovarian transposition: ovarian function and fertility preservation. Int J Radiat Oncol Biol Phys (1993) 1.44
Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol (2000) 1.44
Chemoradiotherapy for localized non-Hodgkin's lymphoma. N Engl J Med (1998) 1.39
Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing. Int J Radiat Oncol Biol Phys (2001) 1.07
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature. Cancer (1989) 1.04
In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival. Int J Radiat Oncol Biol Phys (1994) 1.03
Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology (1996) 1.03
Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? Blood (1994) 0.96
Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int J Cancer (1999) 0.92
A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment. Int J Radiat Oncol Biol Phys (2001) 0.92
Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin's lymphomas. Hematol Oncol (1994) 0.92
CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys (2001) 0.92
Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin. Br J Haematol (1999) 0.91
Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation. Radiother Oncol (1994) 0.91
Unusual localization of cutaneous chronic graft-versus-host disease in the radiation fields in four cases. Bone Marrow Transplant (1989) 0.91
Male pattern baldness and the risk of prostate cancer. Ann Oncol (2011) 0.90
In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. Radiother Oncol (1998) 0.88
In vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation. Br J Radiol (1995) 0.87
Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood (1989) 0.87
Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys (1989) 0.87
[Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]]. Cancer Radiother (2002) 0.86
Cancer of the base of the tongue: past and future. Head Neck (1999) 0.84
Molecular therapy in support to radiotherapy. Mutat Res (2010) 0.84
Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia. Leuk Lymphoma (1992) 0.84
Consequences of two different doses to the lungs during a single dose of total body irradiation: results of a randomized study on 85 patients. Int J Radiat Oncol Biol Phys (1994) 0.83
[Biological equivalency of high single doses used in intraoperative irradiation]. Bull Cancer Radiother (1990) 0.83
Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. EORTC Lymphoma Cooperative Group. Int J Radiat Oncol Biol Phys (1990) 0.83
The radiation accident in Georgia: clinical appearance and diagnosis of cutaneous radiation syndrome. J Am Acad Dermatol (2000) 0.83
Radiation injuries of the gastrointestinal tract in Hodgkin's disease: the role of exploratory laparotomy and fractionation. A study of 19 cases observed in a series of 134 patients treated at the Institut Gustave Roussy from 1972 to 1982. Radiother Oncol (1984) 0.83
Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation. Radiother Oncol (1995) 0.82
Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantation. Int J Radiat Oncol Biol Phys (1995) 0.82
Estimation of clonogenic cell fraction in primary cultures derived from human squamous cell carcinomas. Int J Radiat Oncol Biol Phys (1991) 0.81
[Standards, options and recommendations for the practice of external radiotherapy and brachytherapy in oncology. National Federation of Centers for the fight against Cancer]. Bull Cancer (1995) 0.81
Prognostic factors in non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys (1986) 0.81
Blood cell kinetics and total body irradiation. Radiother Oncol (1987) 0.81
Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease. Transplantation (1990) 0.80
Post-irradiation hyperamylasemia as a biological dosimeter. Radiother Oncol (1992) 0.80
[Respiration-gated radiotherapy: current techniques and potential benefits]. Cancer Radiother (2003) 0.80
[Brachytherapy in the curative treatment of localized prostatic cancer]. Prog Urol (2000) 0.79
[The practical application of computer dosimetry in gynaecological radiotherapy. 1,200 cases studied between 1968 and 1976 of the Gustave-Roussy institute (author's transl)]. J Radiol Electrol Med Nucl (1977) 0.79
Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: the Institut Gustave-Roussy experience. Recent Results Cancer Res (1989) 0.79
[Hyperplasia of the arterial intima due to smooth muscle cell proliferation. Current data, experimental treatments and perspectives]. J Mal Vasc (2003) 0.79
[Diagnostic value of vaginal mouldings in uterine cancer (author's transl)]. J Radiol (1979) 0.79
Comparative analysis of apoptosis measured by Hoechst and flow cytometry in non-Hodgkin's lymphomas. Cytometry (1998) 0.78
Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm. Ann Oncol (1996) 0.78
The prognostic significance of large mediastinal masses in the treatment of Hodgkin's disease. The experience of the Institut Gustave-Roussy. Hematol Oncol (1984) 0.78
The possible role of radiotherapy in chronic lymphocytic leukaemia: a critical review. Radiother Oncol (1985) 0.78
The never-ending controversy about TBI schedules. Radiother Oncol (1992) 0.78
Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial. Radiother Oncol (1984) 0.78
Localized stage non-Hodgkin's lymphoma of the testis: a retrospective study of 16 cases. Nouv Rev Fr Hematol (1995) 0.78
Prospective study of the clinical symptoms of therapeutic whole body irradiation. Health Phys (1993) 0.78
[Radiotherapy for breast cancer: respiratory and set-up uncertainties]. Cancer Radiother (2005) 0.78
[Pulmonary and cardiac late effects of ionizing radiations alone or combined with chemotherapy]. Cancer Radiother (1997) 0.77
Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease. J Clin Oncol (1988) 0.77
[Comparison between single-dose and hyperfractionated total-body irradiation for the conditioning of allogenic grafts of the bone marrow. A retrospective study of 54 patients with malignant hematologic diseases]. Bull Cancer (1988) 0.77
VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease. Bone Marrow Transplant (1998) 0.77
Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia. Leukemia (1998) 0.77
Sequencing of drugs and radiation. The integrated alternating regimen. Cancer (1985) 0.77
Clinical applications of proton therapy. Experiences and ongoing studies. Radiat Environ Biophys (1995) 0.77
In vitro radiation-induced apoptosis and tumour response to radiotherapy: a prospective study in patients with non-Hodgkin lymphomas treated by low-dose irradiation. Int J Radiat Biol (1997) 0.77
Childhood Hodgkin's disease in Campinas, Brazil. Med Pediatr Oncol (1996) 0.76
Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study. Eur J Nucl Med (1992) 0.76
Histopathological and cellular studies of a case of cutaneous radiation syndrome after accidental chronic exposure to a cesium source. Radiat Res (1999) 0.76
Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient. Leuk Lymphoma (1995) 0.76
Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease. Radiother Oncol (1988) 0.75
Electron beam irradiation of conjunctival lymphomas. Int J Radiat Oncol Biol Phys (1991) 0.75
Hematopoiesis research in aplastic anaemia induced by accidental protracted radiation. C R Acad Sci III (1996) 0.75
Similar effects on murine haemopoietic compartment of low dose rate single dose and high dose rate fractionated total body irradiation. Preliminary results after a unique dose of 750 cGy. Br J Cancer (1990) 0.75
[Breast cancer: can tamoxifen, under certain conditions, have adverse effects?]. Bull Cancer (1991) 0.75
Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin's disease treated with mediastinal radiation. Int J Radiat Oncol Biol Phys (2000) 0.75
Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease. Am J Hematol (1991) 0.75
Blood lymphocyte subsets after the first fraction in patients given hyperfractionated total body irradiation for bone marrow transplantation. Br J Cancer (1991) 0.75
[Brachytherapy of the prostatic cancer by interstitial permanent implantation of iodine-125]. Cancer Radiother (2002) 0.75
Hodgkins disease. Br J Cancer (2001) 0.75
[Tumor radiosensitivity tests: state of assays in 1998]. Cancer Radiother (1999) 0.75
[Cancer of the prostate]. Cancer Radiother (2002) 0.75
[Non-small-cell bronchial cancers: improvement of survival probability by conformal radiotherapy]. Cancer Radiother (2002) 0.75
[CT and MR image fusion using two different methods after prostate brachytherapy: impact on post-implant dosimetric assessment]. Cancer Radiother (2003) 0.75
[Cerebral localization of Hodgkin disease: case report and review of the literature]. Cancer Radiother (2002) 0.75
Genetic susceptibility to radiations. Which impact on medical practice? Q J Nucl Med (2000) 0.75
[Ionizing radiation and hyperplasia of the intimal matrix: current data and perspectives]. J Mal Vasc (2002) 0.75
[Conformal radiotherapy: revolution or evolution?]. Cancer Radiother (1999) 0.75
[Biological basis of total body irradiation]. Cancer Radiother (1999) 0.75
[High-dose external ionizing radiation prevents intimal hyperplasia and limits secretion of growth factors PDGFbb, bFGF, and TGFb1. Experiments and results]. J Mal Vasc (2003) 0.75
[Upper aerodigestive tract cancers: clinical benefits of conformal radiotherapy and intensity modulation]. Cancer Radiother (2002) 0.75
[Hodgkin's disease: from gross tumor volume to clinical target volume, firm data and unresolved problems]. Cancer Radiother (2001) 0.75
[A quality control program for radiotherapy in Hodgkin's disease]. Cancer Radiother (1999) 0.75
[Indications for curietherapy of the prostate using permanent implants]. Cancer Radiother (2002) 0.75
[Standards, options and recommendations for the management of adult patients with Hodgkin disease. Standards, Options and Recommendations (SOR) in Cancerology. Groupe d'Etude des Lymphomes de l'Adulte]]. Presse Med (2000) 0.75
[Estimation of the probability of mediastinal involvement: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy in non-small-cell lung cancer?]. Cancer Radiother (2001) 0.75